University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review

University of Texas MD Anderson Cancer Center - Strategic SWOT Analysis Review


  • Products Id :- GDPH23505SA
  • |
  • Pages: 46
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

University of Texas MD Anderson Cancer Center-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

Highlights

University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Anderson provides cancer treatment, cancer research, education and research-based prevention of both common and rare cancers in adult and pediatric patients. Its departments include cancer biology, cancer medicine, cancer systems imaging, cancer prevention and population sciences, clinical cancer prevention, general oncology, hematopathology, gastroenterology, hepatology and nutrition, and genitourinary medical oncology, among others. MD Anderson offers undergraduate, graduate and post-graduate programs, besides research training and nursing education. It operates various research centers, labs and facilities across Texas, New Mexico and New Jersey, the US; Turkey; and Spain. MD Anderson is headquartered in Houston, Texas, the US.

University of Texas MD Anderson Cancer Center Key Recent Developments

Oct 21,2018: Study shows surgery, radiation extend survival of patients with limited metastatic lung cancer

Sep 13,2018: Largest-Ever Study Shows Silicone Breast Implants Associated with Rare Diseases

Sep 10,2018: Study links BAP1 protein to tumor suppression in kidney, eye, bile duct and mesothelioma cancers

Aug 24,2018: USD 50 million awarded by CPRIT to MD Anderson and its projects

Aug 06,2018: Comprehensive CAR t-cell therapy pediatric guidelines developed by MD Anderson in collaboration with the pediatric acute lung injury and sepsis investigators network

Reasons to buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

University of Texas MD Anderson Cancer Center-Key Facts 5

University of Texas MD Anderson Cancer Center-Key Employees 6

University of Texas MD Anderson Cancer Center-Key Employee Biographies 7

University of Texas MD Anderson Cancer Center-Major Products and Services 8

University of Texas MD Anderson Cancer Center-History 9

University of Texas MD Anderson Cancer Center-Company Statement 16

University of Texas MD Anderson Cancer Center-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Joint Venture 18

Section 2-Company Analysis 20

Company Overview 20

University of Texas MD Anderson Cancer Center-Business Description 21

University of Texas MD Anderson Cancer Center-Corporate Strategy 22

University of Texas MD Anderson Cancer Center-SWOT Analysis 23

SWOT Analysis-Overview 23

University of Texas MD Anderson Cancer Center-Strengths 23

University of Texas MD Anderson Cancer Center-Weaknesses 24

University of Texas MD Anderson Cancer Center-Opportunities 25

University of Texas MD Anderson Cancer Center-Threats 26

University of Texas MD Anderson Cancer Center-Key Competitors 27

Section 3-Company's Lifesciences Financial Deals and Alliances 28

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

University of Texas MD Anderson Cancer Center, Recent Deals Summary 30

Section 4-Company's Recent Developments 31

Oct 21, 2018: Study shows surgery, radiation extend survival of patients with limited metastatic lung cancer 31

Sep 13, 2018: Largest-Ever Study Shows Silicone Breast Implants Associated with Rare Diseases 32

Sep 10, 2018: Study links BAP1 protein to tumor suppression in kidney, eye, bile duct and mesothelioma cancers 33

Aug 24, 2018: USD 50 million awarded by CPRIT to MD Anderson and its projects 34

Aug 06, 2018: Comprehensive CAR t-cell therapy pediatric guidelines developed by MD Anderson in collaboration with the pediatric acute lung injury and sepsis investigators network 35

Jul 17, 2018: Therapeutics Discovery drug impairs cancer cells growth and survival 36

Jul 17, 2018: Therapeutics Discovery drug impairs cancer cells growth and survival 39

Jul 12, 2018: Study shows biomarker panel boosts lung cancer risk assessment for smokers 42

Jul 12, 2018: Blood test can help identify the target population to screen for lung cancer 44

Jul 02, 2018: OncLive Presents the Latest State of the Science Summit on Breast Cancer 45

Section 5-Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46

List of Figures

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

List of Tables

University of Texas MD Anderson Cancer Center, Key Facts 5

University of Texas MD Anderson Cancer Center, Key Employees 6

University of Texas MD Anderson Cancer Center, Key Employee Biographies 7

University of Texas MD Anderson Cancer Center, Major Products and Services 8

University of Texas MD Anderson Cancer Center, History 9

University of Texas MD Anderson Cancer Center, Other Locations 17

University of Texas MD Anderson Cancer Center, Subsidiaries 18

University of Texas MD Anderson Cancer Center, Joint Venture 18

University of Texas MD Anderson Cancer Center, Key Competitors 27

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

University of Texas MD Anderson Cancer Center, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

University of Texas MD Anderson Cancer Center, Recent Deals Summary 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

TIRR Memorial Hermann

Texas Children's Cancer Center

Houston Methodist Hospital

Cancer Therapy and Research Center

Baylor St Luke's Medical Center

University of Texas MD Anderson Cancer Center, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.

select a license
Single User License
USD 125 INR 8871
Site License
USD 250 INR 17743
Corporate User License
USD 375 INR 26614

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com